☰

Jared M. Baeten

Affiliations: 
Epidemiology University of Washington, Seattle, Seattle, WA 
Area:
Epidemiology, Public Health
Google:
"Jared Baeten"
Cross-listing: Epi Tree

Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor

Children

Sign in to add trainee
Renee Heffron grad student 2012 University of Washington
Kathryn G. Curran grad student 2013 University of Washington
Erin M. Kahle grad student 2013 University of Washington

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Velloza J, Poovan N, Meisner A, et al. (2024) Adaptive HIV pre-exposure prophylaxis adherence interventions for young women in Johannesburg, South Africa: a sequential multiple-assignment randomised trial. The Lancet. Hiv
Kelley CF, Acevedo-Quiñones M, Agwu AL, et al. (2024) Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons. The New England Journal of Medicine
Peebles K, Matrajt L, Baeten JM, et al. (2024) Understanding the sources of efficacy dilution in a trial of a monthly dapivirine vaginal ring for HIV-1 prevention. International Journal of Std & Aids. 9564624241300199
Mounzer K, Slim J, Ramgopal M, et al. (2024) Efficacy and Safety of Switching to Daily Bictegravir Plus Lenacapavir From a Complex Human Immunodeficiency Virus Treatment Regimen: A Randomized, Open-Label, Multicenter Phase 2 Study (ARTISTRY-1). Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America
Husnik MJ, Heffron R, Hughes JP, et al. (2024) Efficacy of the Dapivirine Vaginal Ring Accounting for Imperfect Adherence. Aids and Behavior
Morrison S, Batting J, Wanga V, et al. (2024) True and false positive HIV point of care test results in a prospective multinational study of at-risk African women: implications for large-scale repeat HIV testing in HIV prevention programs. Journal of Acquired Immune Deficiency Syndromes (1999)
Njuguna N, Akolo C, Anzala O, et al. (2024) Differentiated Service Delivery Models for Maintaining HIV Treatment and Prevention Services During Crisis and Disease Outbreaks: Lessons from the COVID-19 Pandemic. Current Hiv/Aids Reports
Bekker LG, Das M, Abdool Karim Q, et al. (2024) Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women. The New England Journal of Medicine
Wohl DA, Spinner CD, Flamm J, et al. (2024) HIV-1 infection kinetics, drug resistance, and long-term safety of pre-exposure prophylaxis with emtricitabine plus tenofovir alafenamide (DISCOVER): week 144 open-label extension of a randomised, controlled, phase 3 trial. The Lancet. Hiv
Mugambi ML, Odhiambo BO, Dollah A, et al. (2024) Women's preferences for HIV prevention service delivery in pharmacies during pregnancy in Western Kenya: a discrete choice experiment. Journal of the International Aids Society. e26301
See more...